Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Prior Information Notice

Perinatal Immunisation Services in Dorset

  • First published: 27 May 2025
  • Last modified: 27 May 2025
  • Record interest

     

  • This file may not be fully accessible.

  •  

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
ocds-h6vhtk-0515bf
Published by:
NHS England
Authority ID:
AA20005
Publication date:
27 May 2025
Deadline date:
-
Notice type:
Prior Information Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

This notice is published as a Prior Information Notice in order to determine the level of interest from providers in delivering Perinatal Immunisation Services within Dorset.

Perinatal Immunisation Services being commissioned include Pertussis, Flu and COVID-19 vaccinations for pregnant women, Bacillus Calmette-Guérin (BCG) vaccinations for newborn infants, and the roll out of the Respiratory Syncytial Virus (RSV) vaccination programme for pregnant woman over 28 weeks.

The Commissioner seeks Expressions of Interest (EOIs) from providers who have the capability and capacity to deliver Perinatal Immunisation Services within Dorset.

The aim of Perinatal Immunisation Services is to offer vaccination to pregnant women alongside existing planned antenatal appointments, to facilitate improvement of vaccinations offered to newborn infants on a targeted basis (BCG, Hep B as required), to improve data quality, improve uptake and reduce inequalities in access to immunisations across the perinatal pathway. To support the understanding of requirement, the service specifications and sample reporting requirements relating to the individual vaccination programmes have been provided in Atamis.

To co-ordinate delivery of the improvement programme in the system of Dorset, in partnership with the two maternity providers. The programme seeks to

- increase uptake of maternal vaccinations

- improve timeliness of the BCG vaccination programme

- Improve quality of data on uptake and inequalities

- Take steps to address inequalities in accessing these programmes

Further information on this can be found in the Transformation funding outcomes provided in Atamis.

The contract will start on 1st September 2025, it is anticipated that the contract term will be 3 years with a 2 year optional extension.

No changes are foreseen across the life of the contract, other than demographic changes, and increase in income should uptake and activity increase.

We do not believe that TUPE would apply in this award.

The total contract value will be £130,000 per annum plus variable income arising from vaccinations administered for RSV, pertussis and flu. At present this is estimated to be in the region of £120,000 per annum.

Providers who wish to express their interest will need to log into the e-procurement system, Atamis, to access the market engagement questionnaire. Click on 'View our Live Opportunities' from the home page, available on the following link:

https://health-family.force.com/s/Welcome

Once you have found the opportunity (via the search function, using the title or reference number), to gain full access to the relevant information and market engagement questionnaire, you will need to click on 'Register interest' - this will take you to the log-in page.

If you are not already registered on the system, you will need to do so before gaining full access to be able to submit your expression of interest / completed market engagement questionnaire.

Expressions of interest / completed market engagement questionnaire must be received by no later than 12 noon on Friday 6th June 2025.

This exercise is being carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioner.

Full notice text

Prior information notice

This notice is for prior information only

Section I: Contracting authority

I.1) Name and addresses

NHS ENGLAND

Wellington House, 133-135 Waterloo Road

London

SE1 8UG

UK

Contact person: Rebecca Rogers

E-mail: scwcsu.procurement@nhs.net

NUTS: UKI

Internet address(es)

Main address: https://www.england.nhs.uk

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

https://atamis-1928.my.site.com/s/Welcome


Additional information can be obtained from the abovementioned address


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Perinatal Immunisation Services in Dorset

Reference number: C357533

II.1.2) Main CPV code

85140000

 

II.1.3) Type of contract

Services

II.1.4) Short description

This notice is published as a Prior Information Notice in order to determine the level of interest from providers in delivering Perinatal Immunisation Services within Dorset.

Perinatal Immunisation Services being commissioned include Pertussis, Flu and COVID-19 vaccinations for pregnant women, Bacillus Calmette-Guérin (BCG) vaccinations for newborn infants, and the roll out of the Respiratory Syncytial Virus (RSV) vaccination programme for pregnant woman over 28 weeks.

The Commissioner seeks Expressions of Interest (EOIs) from providers who have the capability and capacity to deliver Perinatal Immunisation Services within Dorset.

The aim of Perinatal Immunisation Services is to offer vaccination to pregnant women alongside existing planned antenatal appointments, to facilitate improvement of vaccinations offered to newborn infants on a targeted basis (BCG, Hep B as required), to improve data quality, improve uptake and reduce inequalities in access to immunisations across the perinatal pathway. To support the understanding of requirement, the service specifications and sample reporting requirements relating to the individual vaccination programmes have been provided in Atamis.

To co-ordinate delivery of the improvement programme in the system of Dorset, in partnership with the two maternity providers. The programme seeks to

- increase uptake of maternal vaccinations

- improve timeliness of the BCG vaccination programme

- Improve quality of data on uptake and inequalities

- Take steps to address inequalities in accessing these programmes

Further information on this can be found in the Transformation funding outcomes provided in Atamis.

The contract will start on 1st September 2025, it is anticipated that the contract term will be 3 years with a 2 year optional extension.

No changes are foreseen across the life of the contract, other than demographic changes, and increase in income should uptake and activity increase.

We do not believe that TUPE would apply in this award.

The total contract value will be £130,000 per annum plus variable income arising from vaccinations administered for RSV, pertussis and flu. At present this is estimated to be in the region of £120,000 per annum.

Providers who wish to express their interest will need to log into the e-procurement system, Atamis, to access the market engagement questionnaire. Click on 'View our Live Opportunities' from the home page, available on the following link:

https://health-family.force.com/s/Welcome

Once you have found the opportunity (via the search function, using the title or reference number), to gain full access to the relevant information and market engagement questionnaire, you will need to click on 'Register interest' - this will take you to the log-in page.

If you are not already registered on the system, you will need to do so before gaining full access to be able to submit your expression of interest / completed market engagement questionnaire.

Expressions of interest / completed market engagement questionnaire must be received by no later than 12 noon on Friday 6th June 2025.

This exercise is being carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioner.

II.1.5) Estimated total value

Value excluding VAT: 1 250 000.00  GBP

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.2) Additional CPV code(s)

33651000

II.2.3) Place of performance

NUTS code:

UKK25

II.2.4) Description of the procurement

This notice is published as a Prior Information Notice in order to determine the level of interest from providers in delivering Perinatal Immunisation Services within Dorset.

Perinatal Immunisation Services being commissioned include Pertussis, Flu and COVID-19 vaccinations for pregnant women, Bacillus Calmette-Guérin (BCG) vaccinations for newborn infants, and the roll out of the Respiratory Syncytial Virus (RSV) vaccination programme for pregnant woman over 28 weeks.

The Commissioner seeks Expressions of Interest (EOIs) from providers who have the capability and capacity to deliver Perinatal Immunisation Services within Dorset.

The aim of Perinatal Immunisation Services is to offer vaccination to pregnant women alongside existing planned antenatal appointments, to facilitate improvement of vaccinations offered to newborn infants on a targeted basis (BCG, Hep B as required), to improve data quality, improve uptake and reduce inequalities in access to immunisations across the perinatal pathway. To support the understanding of requirement, the service specifications and sample reporting requirements relating to the individual vaccination programmes have been provided in Atamis.

To co-ordinate delivery of the improvement programme in the system of Dorset, in partnership with the two maternity providers. The programme seeks to

- increase uptake of maternal vaccinations

- improve timeliness of the BCG vaccination programme

- Improve quality of data on uptake and inequalities

- Take steps to address inequalities in accessing these programmes

Further information on this can be found in the Transformation funding outcomes provided in Atamis.

The contract will start on 1st September 2025, it is anticipated that the contract term will be 3 years with a 2 year optional extension.

No changes are foreseen across the life of the contract, other than demographic changes, and increase in income should uptake and activity increase.

We do not believe that TUPE would apply in this award.

The total contract value will be £130,000 per annum plus variable income arising from vaccinations administered for RSV, pertussis and flu. At present this is estimated to be in the region of £120,000 per annum.

Providers who wish to express their interest will need to log into the e-procurement system, Atamis, to access the market engagement questionnaire. Click on 'View our Live Opportunities' from the home page, available on the following link:

https://health-family.force.com/s/Welcome

Once you have found the opportunity (via the search function, using the title or reference number), to gain full access to the relevant information and market engagement questionnaire, you will need to click on 'Register interest' - this will take you to the log-in page.

If you are not already registered on the system, you will need to do so before gaining full access to be able to submit your expression of interest / completed market engagement questionnaire.

Expressions of interest / completed market engagement questionnaire must be received by no later than 12 noon on Friday 6th June 2025.

This exercise is being carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioner.

II.3) Estimated date of publication of contract notice:

01/07/2025

Section IV: Procedure

IV.1) Description

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

Section VI: Complementary information

VI.3) Additional information

Interested providers will be able to view this opportunity via the live opportunities list on the 'Health Family' e-procurement system, Atamis. Click on 'View our Live Opportunities' from the home page, available on the following link: https://health-family.force.com/s/Welcome.

Once you have found the opportunity (via the search function, using the title or reference number), to gain full access to the relevant information, you will need to click on 'Register interest' - this will take you to the log-in page.

If you are not already registered on the system, you will need to do so before gaining full access to the documentation and to be able to submit your expression of interest and completed questionnaire using the correspondence function within Atamis.

Decision makers - Managing Director (system development Yand commissioning) and South West System Oversight and Co-ordination Leadership Team

This is a Prior Information Notice, to help the Commissioner understand the market interest. The awarding of this contract will be subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

VI.5) Date of dispatch of this notice

16/05/2025

Coding

Commodity categories

ID Title Parent category
33651000 General anti-infectives for systemic use and vaccines General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
85140000 Miscellaneous health services Health services

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
scwcsu.procurement@nhs.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.